Role of Duloxetine as Adjuvant in Chemotherapy Induced Peripheral Neuropathic Pain-An Update
<p>Chemotherapy-induced peripheral neuropathy (CIPN) is a common side effect of many anticancer drugs such as platinum compounds, antitubulins (taxanes and vinca alkaloids), bortezomib and thalidomide [1]. CIPN may manifest as sensory symptoms in hands and feet, typically in a "glove and...
Saved in:
Main Authors: | Kalpajit Dutta (Author), Rakesh Garg (Author) |
---|---|
Format: | Book |
Published: |
Journal of Addiction Medicine and Therapeutic Science - Peertechz Publications,
2016-06-29.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A review of the clinical utility of duloxetine in the treatment of diabetic peripheral neuropathic pain
by: King JB, et al.
Published: (2015) -
The Role of Vascular-Immune Interactions in Modulating Chemotherapy Induced Neuropathic Pain
by: Tameille Valentine, et al.
Published: (2022) -
Duloxetine, a Balanced Serotonin-Norepinephrine Reuptake Inhibitor, Improves Painful Chemotherapy-Induced Peripheral Neuropathy by Inhibiting Activation of p38 MAPK and NF-κB
by: Jing Meng, et al.
Published: (2019) -
Effectiveness of Duloxetine versus Other Therapeutic Modalities in Patients with Diabetic Neuropathic Pain: A Systematic Review and Meta-Analysis
by: Juan José Valenzuela-Fuenzalida, et al.
Published: (2024) -
Peripheral Mechanisms of Neuropathic Pain-The Role of Neuronal and Non-Neuronal Interactions and Their Implications for Topical Treatment of Neuropathic Pain
by: Magdalena Kocot-Kępska, et al.
Published: (2021)